← All roles

Head of Expansion at AIOS — Remote, $200-$400k/yr + .15% - 0.5% equity

AIOS· Operations
Apply on company site
Hybrid (Remote (EU timezone))$200k - $400k + equityFull-timePosted 1w ago

About the role

Senior operations role focused on rapid, compliant expansion of AIOS across European markets, driving market-entry from research to live operations and building a repeatable playbook for blitzscale country launches.

Responsibilities

  • Expansion: Own European expansion from market research through launch readiness, turning “we should enter this country” into “we can compliantly serve patients here”, then repeat the process faster every time.
  • Prioritisation: Determine which countries to enter next based on market size, customer demand, unit economics, regulatory complexity and speed to launch.
  • Planning: Identify blockers to launching in each priority country and construct the plan to overcome them.
  • Build or Buy: Choose fastest compliant route into each market—internal build, partnerships with local providers, or acquiring existing infrastructure.
  • Legal & Regulatory: Ensure appropriate legal entities, permissions, registrations and compliance frameworks.
  • Clinical: Establish clinical infrastructure to serve patients, including staffing initial clinical team if building from scratch.
  • Supply & Fulfilment: Secure medication supply, pharmacy partners, and fulfilment infrastructure for rapid scale.
  • Readiness: Coordinate legal/clinical/product/operational/supply work to enable Growth to begin testing markets quickly.
  • Playbook: Turn learnings into a repeatable system to reduce time, cost, and complexity for future country entries.

Qualifications

  • Experience: 5+ years in expansion, market launch, business operations, general management, or similarly high-ownership role (startup speed preferred).
  • Locale: Based in the UK or Europe, with launches/scaling across multiple European countries (Germany, Netherlands, France, Spain, Italy, Nordics).
  • Launches: Personally owned taking European launches from idea to live operations.
  • Judgement: Ability to decide which markets are worth entering and whether to build, partner, or acquire.
  • Execution: Comfortable moving from strategy to trenches, negotiating partnerships, reviewing contracts, setting up entities, addressing supply constraints.
  • Complexity: Able to navigate complex regulatory environments and coordinate across legal, clinical, and ops with ownership.
  • Clockspeed: Rapid learner of unfamiliar markets; identify blockers and reach high-quality decisions quickly.
  • Project Management: Manage multiple country launches concurrently with clear DRIs and deadlines.
  • Systems: Create reusable scaffolding across Europe to shorten future launch times.
  • Ownership: Act like a founder; take responsibility until patients are served.

Skills

Required:Expansion leadershipMarket prioritizationRegulatory strategyNegotiation & partnershipsProgram/project management

Benefits

  • Healthcare: comprehensive medical insurance (if appropriate).
  • Vacation: PTO with minimum 2 weeks/year plus holidays.
  • Personal development: budget for books, courses, coaching.
  • Personal wellness: budget for gym and health apps.
  • GLP-1s: free clinic membership for GLP-1s.
  • Equipment: MacBook & home-office setup provided as needed.
Last updated Oct 25, 2026. Interested? Apply on the company site.
AIOS logo

About AIOS

Building AI-native infrastructure for the next era of care.

Our overarching mission is to build the AI operating system for consumer healthcare - delivering end-to-end care with near-zero marginal human time. We believe the future of healthcare is automated, intelligent, radically lower cost, and built around the consumer. We believe biology is entering a golden age. We believe profitable, focused companies beat bloated ones. We're determined to get the humans out of healthcare - replacing slow, expensive, legacy workflows with software-driven care delivered at scale. We’ve started by building this infrastructure to power our own brands - including Bolt Pharmacy and Fella Health, among others. Today, that infrastructure is helping patients access life-changing treatment for excess bodyweight. Over time, we’ll extend it across many of the categories that will define the next era of healthcare. Our infrastructure will have served 100 million patients worldwide by 2035. We’ll then use that infrastructure to deliver next-generation healthcare products at massive scale. In doing so, we aim to build the world’s first trillion-dollar healthcare company.

Consumer Health ServicesHealth TechHealthcareTelemedicine
Company profileWebsite